// App-Quantinova.ai

S251 : DISRUPTION OF SUCCINATE RECEPTOR SIGNALING PROMOTES MYELOPROLIFERATION AND ACUTE MYELOID LEUKAEMIA

Researchers

Presenter

  • Vincent Cuminetti

Principal Investigators

  • Joanna Konieczny

  • Aurora Bernal

  • Alicia Villatoro

  • Hagar Taman

  • Marko Ristic

  • Nuria Villaplana-Lopera

  • Ruth H. Paulssen

  • Giovanna Giovinazzo

  • Paloma Garcia

  • Lorena Arranz

Medical Centers

  • IMB, Stem Cells Ageing and Cancer,UiT The Arctic University of Norway,Tromsø,Norway

  • Department of Oncology, University Hospital of North Norway, Troms, Norway

  • Department of Oncology, University Hospital of North Norway, Troms, Norway

  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

  • Department of Oncology, University Hospital of North Norway, Troms, Norway

  • IMB, Stem Cells Ageing and Cancer,UiT The Arctic University

  • Pluripotent Cell Technology Unit,Centro Naciona

  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

  • Pluripotent Cell Technology Unit,Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spagna

  • Genomics Support Center Tromsø,UiT The Arctic University of Norway,Tromsø,Norvège

  • Department of Oncology, University Hospital of North Norway, Troms, Norway

  • Genomics Support Center Tromsø,UiT The Arctic University of Norway,Tromsø,Norvège

  • IMB, Stem Cells Ageing and Cancer,UiT The Arctic University of Norway,Tromsø,Norway

  • Pluripotent Cell Technology Unit,Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spagna

  • Institute of Cancer and Genomi

  • Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom

  • Genomics Support Center Tromsø,UiT The Arctic University of Norway,Tromsø,Norvège

  • IMB, Stem Cells Ageing and Cancer,UiT The Arctic University of Norway,Tromsø,Norway

  • Pluripotent Cell Technology Unit,Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spagna

  • Genomics Support Center Tromsø,UiT The Arctic University of Norway,Tromsø,Norvège

  • IMB, Stem Cells Ageing and Cancer,UiT The Arctic University of Norway,Tromsø,Norway

  • Department of Oncology, University Hospital of North Norway, Troms, Norway

  • Genomics Support Center Tromsø,UiT The Arctic University of Norway,Tromsø,Norvège

Locations

  • Norway

  • United States

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • Peripheral blood mononuclear cell

  • Cluster of Differentiation 34

Drug/Treatment

  • Tamoxifen

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved